Certified by Founder
Lodge
KROMATID®
start up
United States
- Longmont, Colorado
- 21/08/2025
- Series C
- $8,000,000
Revolutionizing gene editing analysis for precision medicine and cutting-edge research.
For cell and gene therapy researchers, biotech and pharma companies, and regulatory professionals, KROMATID’s KROMASURE Platform is the genomic characterization solution that provides high-confidence, single-cell insights into chromosomal integrity, structural variants, and transgene mapping.
Unlike traditional sequencing methods, our technology directly visualizes up to thousands of single cells at a time, offering scalable, actionable data with unprecedented clarity, helping you confidently advance research and meet FDA regulatory requirements.
Visit our website to learn how we can support your research.
- Industry Biotechnology Research
- Website https://kromatid.com/
- LinkedIn https://www.linkedin.com/company/kromatid/
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
CoreStory | $32,000,000 | (Oct 29, 2025)
Paygentic | $2,000,000 | (Oct 28, 2025)
SavvyMoney | $225,000,000 | (Oct 28, 2025)
Natural | $9,800,000 | (Oct 28, 2025)
WideField Security | $11,300,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
WorkHero | $5,000,000 | (Oct 28, 2025)
Seneca | $60,000,000 | (Oct 28, 2025)
Honey Health | $7,800,000 | (Oct 28, 2025)